| Delårsrapport januari – september 2017 | Report (pdf) |
| Interim report January – September 2017 | Report (pdf) |
| Delårsrapport januari – juni 2017 | Report (pdf) |
| Interim report January – June 2017 | Report (pdf) |
| Delårsrapport januari – mars 2017 | Report (pdf) |
| Interim report January – March 2017 | Report (pdf) |
The RespiraSense™ business model consists of several components that together create a complete delivery that generates attractive gross margins and recurring revenues.
To avoid preventable respiratory failure events by transforming the standard of care in patient monitoring.
To become the de facto standard-of-care for monitoring respiratory compromised patients in Europe and the US.